Home Articles Service Price About

Advanced Micro Devices

Search Result

Firm

박재훈투영인

Buy the Second-Best Stock (May 14, 2025)

Neutral

TSLA

Tesla

+2

박재훈투영인

Buy the Second-Best Stock (May 14, 2025)

According to Scott Nations, president of Nations Indexes, investors should consider taking a bullish stance on Advanced Micro Devices (AMD) following a series of positive headlines surrounding the stock. Appearing on CNBC’s “Power Lunch” on Wednesday, Nations also discussed two of the day’s biggest stock stories and shared whether investors should consider buying or selling those names.Advanced Micro DevicesShares of the AI chipmaker jumped more than 4% on Wednesday after the company announced that its board had approved a $6 billion share repurchase program.Nations rated AMD a “buy,” pointing out that former President Donald Trump is reportedly planning to roll back restrictions on U.S. chip exports—something he said would be “positive for the entire sector.” He also called AMD the “second-best name” in the space, citing the company’s recent deal with Saudi firm Humain to help build out AI infrastructure, alongside Nvidia.“If you’re looking to invest in AI, this is a chance to buy at a 35% discount from its 52-week high,” Nations said. While AMD has rallied nearly 25% over the past month, it’s still down more than 2% year-to-date.AbbVieBiotech giant AbbVie saw its stock fall over 5% during Wednesday’s session.Citi downgraded the stock from Buy to Neutral and lowered its price target by $5 to $205 per share, still implying over 15% upside. Analyst Geoff Meacham noted that despite AbbVie’s track record of “consistent beats and raised guidance,” the company’s late-stage pipeline appears weak relative to peers.“Fundamentals are solid right now,” Meacham wrote in a note to clients, “but as investors increasingly focus on pipeline strength, the impact of quarterly surprises could begin to fade.”Nations disagreed strongly with that take, calling the downgrade “truly foolish” and reiterating his “buy” rating on AbbVie. “Pipeline matters for every pharma company, but AbbVie keeps beating earnings expectations, raising dividends, and offers a solid 3.5% yield. It’s in a good space,” he said. The stock is down 8% over the past three months.TeslaTesla shares climbed 4% on Wednesday after Reuters, citing sources familiar with the matter, reported that the EV maker will begin shipping components for its Cybercab and Semi truck from China to the U.S. later this month. The report came after the U.S. and China agreed earlier this week to temporarily suspend certain tariffs for 90 days.The development comes as Tesla grapples with declining sales in China and intensifying competition from local automakers. “I see Tesla as a hold right now,” Nations said. “It’s good that they’re resuming imports from China, but don’t forget: there are still some hefty tariffs on Chinese goods. In about 85 days, those could jump again—maybe even triple.”Tesla shares surged nearly 26% last week but remain down about 14% during that same period, leaving the stock still in negative territory for the year.[Compliance Note]All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.

article

Neutral

TSLA

Tesla

+2

셀스마트 판다

AMD Faces $800M Hit as U.S. Tightens Export Controls on AI Chips (Apr 17, 2025)

Strong Sell

AMD

Advanced Micro Devices

셀스마트 판다

AMD Faces $800M Hit as U.S. Tightens Export Controls on AI Chips (Apr 17, 2025)

AMD has warned of a potential $800 million loss in its Q1 2025 results due to new export restrictions imposed by the U.S. government. The move targets its MI308 AI chip, now subject to a newly enforced export license requirement as part of Washington’s tightening policy on advanced semiconductor shipments to China.The projected loss includes provisions for inventory, supplier agreements, and related reserves—and could widen further if restrictions remain in place or expand.China accounted for approximately 24% of AMD’s 2024 revenue, or $6.2 billion, making it one of the company’s most critical markets. However, U.S. authorities have never granted licenses for GPU exports to China, and this latest directive appears to carry no defined expiration period. Although AMD plans to apply for a license, approval remains uncertain.The market responded swiftly. AMD shares fell more than 5% following the announcement, and other chipmakers with significant China exposure saw similar pressure. With escalating trade tensions and policy unpredictability, AMD faces risks that extend well beyond one quarter.[Compliance Note]All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.

article

Strong Sell

AMD

Advanced Micro Devices

셀포터즈 박소연

In the Age of AI, Why Has AMD Failed to Rebound? (Apr 9, 2025)

Neutral

AMD

Advanced Micro Devices

셀포터즈 박소연

In the Age of AI, Why Has AMD Failed to Rebound? (Apr 9, 2025)

The semiconductor industry in 2025 is at a turning point—AI presents a massive opportunity, but also sharpens the risks tied to technological disparity, demand imbalances, and geopolitical volatility. While Nvidia maintains its dominance and Intel accelerates strategic changes, AMD once again finds itself caught between market skepticism and latent expectations.Its technological prowess is unquestioned, but in today’s market, potential is no longer enough. AMD must deliver measurable results.The Fall Behind the NumbersAMD (Advanced Micro Devices) has long stood as a key player between Intel and Nvidia, bolstered by its innovation in high-performance CPUs and GPUs under the leadership of CEO Lisa Su. The company enjoyed significant gains in both product leadership and investor sentiment.But since late 2024, its stock has told a different story. In 2025 alone, AMD shares are down over 20%, diverging sharply from Nvidia’s strong upward trajectory. The decline reflects several compounding factors: relative underperformance in AI semiconductors, a slowdown in server demand, and weaker consumer product sales.The immediate catalyst was AMD’s Q4 2024 earnings, which, despite year-over-year revenue growth, fell short of market expectations—particularly in the data center segment, where slower-than-anticipated growth led to broad disappointment.Entering AI—But Not Yet DeliveringAMD has staked its future AI ambitions on the MI300 series, targeting cloud service providers and AI workloads with high-performance GPUs. The company has signaled an expansion in partnerships and product deployments.However, these developments have yet to translate into meaningful revenue. AMD has stated that MI300-related sales will begin contributing in earnest from mid-2025, but for now, investors remain on hold.Meanwhile, Intel is reasserting itself with next-gen CPU launches and a revitalized foundry business, and Nvidia’s dominance in AI chips remains unshaken. In such a competitive environment, AMD’s performance suggests that technical merit alone is no longer enough to drive a stock recovery.Conclusion: It Comes Down to ExecutionAMD is at another crossroads. Its AI roadmap via the MI300, potential recovery in the server and PC markets, and growing partnerships all present legitimate upside. But markets now demand execution over narrative.In the past, AMD has navigated similar inflection points by proving both its innovation and operational discipline. This time, however, the company must move faster—and with greater clarity.The mission for 2025 is simple: turn technology into results. If AMD succeeds, the current downturn may well prove to be a long-term buying opportunity. That’s why its next steps matter more than ever.[Compliance Note]All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.

article

Neutral

AMD

Advanced Micro Devices

셀스마트 대니

📉 S&P 500 Stocks with Over 10% Target Price Downgrade in the 4th Week of March (AES, ALB, AMD, BF.B, BIIB)

Strong Sell

AMD

Advanced Micro Devices

+4

셀스마트 대니

📉 S&P 500 Stocks with Over 10% Target Price Downgrade in the 4th Week of March (AES, ALB, AMD, BF.B, BIIB)

Over the past 8 weeks (from Jan 24 to Mar 21, 2025), analyst reports covering major S&P 500 companies revealed several stocks whose target prices were revised downward by more than 10%.This is interpreted as a reflection of changes in company fundamentals, macroeconomic factors, and shifts in industry competition. From a sell-side perspective, such target price cuts may indicate short-term downside pressure, suggesting that investors should consider proper risk management and exit strategies.Below are details of companies with target prices lowered by more than 10% compared to 8 weeks ago. Each company's target price as of Jan 24 and Mar 21, 2025, is provided, along with the percentage decrease.1. AES (AES-US)Target Price (Mar 21, 2025): $15Target Price (Jan 24, 2025): $17Change: -11.8%Key Issue: Slowing growth in the power and utility sectors and rising energy costs are putting pressure on profitability.2. Albemarle (ALB-US)Target Price (Mar 21, 2025): $98Target Price (Jan 24, 2025): $112Change: -12.5%Key Issue: Volatility in the lithium market—a key material for EV batteries—and concerns over economic slowdown have led to lowered sales growth expectations.3. Advanced Micro Devices (AMD-US)Target Price (Mar 21, 2025): $145Target Price (Jan 24, 2025): $171Change: -15.2%Key Issue: Ongoing concerns around weakening demand in the PC and data center markets, along with intensified competition and macroeconomic uncertainty, are undermining short-term earnings momentum.4. Brown Forman Class B (BF.B-US)Target Price (Mar 21, 2025): $40Target Price (Jan 24, 2025): $46Change: -13.0%Key Issue: Weak consumer demand and rising raw material costs are squeezing margins, while intensified global competition in the alcohol market is limiting growth prospects.5. Biogen (BIIB-US)Target Price (Mar 21, 2025): $198Target Price (Jan 24, 2025): $228Change: -13.2%Key Issue: Uncertainty around the clinical results of new drugs and increased competition have led to lower sales estimates. Regulatory risks are also being cited as a potential concern.While the reasons and extent of the target price downgrades vary by company, they broadly reflect macro-level risks such as recession concerns, supply chain issues, cost inflation, and intensifying industry competition. In some cases, structural changes in the respective industries (e.g., EV battery demand volatility, semiconductor market conditions) played a significant role.From a sell-side strategy perspective, these stocks are likely to face near-term downward momentum. Investors should consider adjusting their portfolio exposures or evaluating short-position strategies. Volatility could also increase depending on upcoming earnings announcements, interest rate movements, and macroeconomic indicators, so a flexible approach aligned with market trends is essential.[Compliance Note]All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.

article

Strong Sell

AMD

Advanced Micro Devices

+4

Event

셀스마트 대니

S&P 500 Stocks with Over 10% Target Price Downgrades – Part 2 📉 (3rd Week of March)

Strong Sell

AMD

Advanced Micro Devices

+26

셀스마트 대니

S&P 500 Stocks with Over 10% Target Price Downgrades – Part 2 📉 (3rd Week of March)

Over the past eight weeks (Jan 17, 2025 – Mar 12, 2025), several major S&P 500 companies have seen their target prices cut by more than 10% in analyst reports.This reflects a combination of fundamental shifts in these companies, macroeconomic factors, and changes in industry competition. From a sell-side perspective, such target price downgrades can signal short-term downward pressure on stock prices, requiring investors to consider appropriate risk management and sell strategies.Below is a list of stocks whose target prices have been cut by more than 10% compared to eight weeks ago. For each stock, we provide the target price as of January 17, 2025, and March 12, 2025, along with the percentage decrease.1. AES (AES-US)Target Price (Mar 12, 2025): $15Target Price (Jan 17, 2025): $18Decline: -16.7%Key Issue: Slower growth in the power and utilities sector, combined with rising energy costs, is pressuring the company’s profitability.2. Albemarle (ALB-US)Target Price (Mar 12, 2025): $98Target Price (Jan 17, 2025): $112Decline: -12.5%Key Issue: Falling lithium prices and declining global EV demand are negatively impacting the company’s earnings outlook.3. Advanced Micro Devices (AMD-US)Target Price (Mar 12, 2025): $147Target Price (Jan 17, 2025): $173Decline: -15.0%Key Issue: Slowing demand in the data center and PC markets, along with intensified AI competition, has led to downward earnings revisions.4. Biogen (BIIB-US)Target Price (Mar 12, 2025): $198Target Price (Jan 17, 2025): $228Decline: -13.2%Key Issue: Delays in new drug approvals and growing competition are raising concerns about the company’s revenue growth.5. Builders FirstSource (BLDR-US)Target Price (Mar 12, 2025): $178Target Price (Jan 17, 2025): $203Decline: -12.3%Key Issue: A slowdown in the construction industry and rising raw material costs are putting pressure on profitability.6. Celanese (CE-US)Target Price (Mar 12, 2025): $69Target Price (Jan 17, 2025): $93Decline: -25.8%Key Issue: Weakening demand for chemical products and rising raw material costs are negatively affecting earnings.7. Charles River Laboratories (CRL-US)Target Price (Mar 12, 2025): $183Target Price (Jan 17, 2025): $204Decline: -10.3%Key Issue: Increased competition in the pharmaceutical research and lab supply market is putting pressure on growth projections.8. Electronic Arts (EA-US)Target Price (Mar 12, 2025): $144Target Price (Jan 17, 2025): $163Decline: -11.7%Key Issue: Increased competition in the gaming industry and weaker-than-expected demand for new releases are weighing on revenue forecasts.9. Edison International (EIX-US)Target Price (Mar 12, 2025): $71Target Price (Jan 17, 2025): $86Decline: -17.4%Key Issue: Profitability concerns in the utilities sector and growing regulatory pressures have led to a target price reduction.10. Enphase Energy (ENPH-US)Target Price (Mar 12, 2025): $78Target Price (Jan 17, 2025): $89Decline: -12.4%Key Issue: Slower growth in the renewable energy market and rising raw material costs are weighing on the company’s performance.11. Fidelity National Information Services (FIS-US)Target Price (Mar 12, 2025): $83Target Price (Jan 17, 2025): $93Decline: -10.8%Key Issue: Increased competition in financial services and payment processing is impacting earnings outlooks.12. FMC (FMC-US)Target Price (Mar 12, 2025): $49Target Price (Jan 17, 2025): $67Decline: -26.9%Key Issue: Weak demand for agricultural chemicals and rising input costs are pressuring earnings expectations.13. Huntington Ingalls Industries (HII-US)Target Price (Mar 12, 2025): $199Target Price (Jan 17, 2025): $224Decline: -11.2%Key Issue: Changes in defense and shipbuilding budgets, along with reductions in government spending, have weighed on earnings projections.14. Hewlett Packard Enterprise (HPE-US)Target Price (Mar 12, 2025): $20Target Price (Jan 17, 2025): $24Decline: -16.7%Key Issue: Slowing demand for enterprise IT infrastructure and increased competition in the cloud computing market are affecting the company’s growth prospects.15. Kraft Heinz (KHC-US)Target Price (Mar 12, 2025): $32Target Price (Jan 17, 2025): $36Decline: -11.1%Key Issue: Rising raw material costs and changing consumer spending habits highlight the need for brand competitiveness improvements.16. Microchip Technology (MCHP-US)Target Price (Mar 12, 2025): $66Target Price (Jan 17, 2025): $80Decline: -17.5%Key Issue: Short-term uncertainties in the semiconductor industry and inventory adjustments are negatively impacting earnings expectations.17. Mondelez International Class A (MDLZ-US)Target Price (Mar 12, 2025): $67Target Price (Jan 17, 2025): $75Decline: -10.7%Key Issue: Slowing global consumer goods market growth and rising raw material costs are increasing margin pressures.18. MarketAxess Holdings (MKTX-US)Target Price (Mar 12, 2025): $232Target Price (Jan 17, 2025): $259Decline: -10.4%Key Issue: Increased competition in the bond trading platform market and interest rate volatility are affecting revenue growth.19. Moderna (MRNA-US)Target Price (Mar 12, 2025): $53Target Price (Jan 17, 2025): $69Decline: -23.2%Key Issue: Declining COVID-19 vaccine demand and uncertainties in new drug development are impacting investor sentiment.20. NetApp (NTAP-US)Target Price (Mar 12, 2025): $123Target Price (Jan 17, 2025): $138Decline: -10.9%Key Issue: Increased competition in the data storage and cloud solutions market is slowing the company’s growth trajectory.21. ON Semiconductor (ON-US)Target Price (Mar 12, 2025): $61Target Price (Jan 17, 2025): $79Decline: -22.8%Key Issue: Strong demand for automotive semiconductors is offset by weak IT and consumer electronics demand, leading to lower revenue forecasts.22. Sempra (SRE-US)Target Price (Mar 12, 2025): $83Target Price (Jan 17, 2025): $94Decline: -11.7%Key Issue: Market volatility in the energy and utilities sector and changing regulatory environments are weighing on profitability forecasts.23. Skyworks Solutions (SWKS-US)Target Price (Mar 12, 2025): $72Target Price (Jan 17, 2025): $97Decline: -25.8%Key Issue: Weakening demand for 5G components and increasing competition in the smartphone market are negatively impacting growth.24. Teleflex (TFX-US)Target Price (Mar 12, 2025): $165Target Price (Jan 17, 2025): $240Decline: -31.3%Key Issue: Slowing demand in the medical device market and global economic uncertainty are lowering earnings projections.25. United Parcel Service Class B (UPS-US)Target Price (Mar 12, 2025): $131Target Price (Jan 17, 2025): $148Decline: -11.5%Key Issue: Slowing growth in the global logistics market and rising costs are putting pressure on profit margins.26. Western Digital (WDC-US)Target Price (Mar 12, 2025): $79Target Price (Jan 17, 2025): $88Decline: -10.2%Key Issue: Short-term weakness in the memory semiconductor market and declining prices are impacting revenue and profitability.27. West Pharmaceutical Services (WST-US)Target Price (Mar 12, 2025): $281Target Price (Jan 17, 2025): $377Decline: -25.5%Key Issue: Rising raw material costs and increasing competition in the pharmaceutical and medical device industries are pressuring growth expectations.While the reasons and extent of target price downgrades vary by company, overall, these revisions reflect common macroeconomic risks, such as economic recession fears, supply chain uncertainties, rising costs, intensifying competition.Additionally, some companies are affected by structural industry changes, such as fluctuations in EV battery demand and semiconductor industry trends.From a sell-side perspective, stocks experiencing significant target price cuts could face short-term downside pressure. Investors should consider risk management strategies, including portfolio rebalancing, short positions, market-driven adjustments – Stay alert to upcoming earnings reports, interest rate changes, and key economic indicators, as these can significantly impact volatility.By aligning investment decisions with broader market trends, investors can navigate these shifts with greater flexibility and strategic foresight.[Compliance Note]All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.

article

Strong Sell

AMD

Advanced Micro Devices

+26

셀스마트 대니

S&P 500 Stocks with Over 10% Target Price Downgrade 📉 (3rd Week of Feb 2025)

Strong Sell

AMD

Advanced Micro Devices

+10

셀스마트 대니

S&P 500 Stocks with Over 10% Target Price Downgrade 📉 (3rd Week of Feb 2025)

Over the past four weeks (Jan 24, 2025 – Feb 18, 2025), several major S&P 500 companies have seen their target prices cut by more than 10% in analyst reports.This reflects a combination of fundamental shifts in these companies, macroeconomic factors, and changes in industry competition. From a sell-side perspective, such target price downgrades can signal short-term downward pressure on stock prices, requiring investors to consider appropriate risk management and sell strategies.Below is a list of stocks whose target prices have been cut by more than 10% compared to four weeks ago. For each stock, we provide the target price as of January 24, 2025, and February 18, 2025, along with the percentage decrease.1. Albemarle (ALB-US)Target Price (Feb 18, 2025): $292Target Price (Jan 24, 2025): $322Decline: -10.7%Key Issue: Concerns over the volatility of the lithium market, a key material for EV batteries, and macroeconomic slowdown have led to a downward revision in sales growth expectations.2. Advanced Micro Devices (AMD-US)Target Price (Feb 18, 2025): $148Target Price (Jan 24, 2025): $171Decline: -13.5%Key Issue: Weak demand in the PC and data center markets, as well as increased competition and macroeconomic uncertainties, have raised concerns about short-term earnings momentum.3. Biogen (BIIB-US)Target Price (Feb 18, 2025): $299Target Price (Jan 24, 2025): $342Decline: -12.6%Key Issue: Uncertainty surrounding the clinical results of key drugs and increased competition have led to lower revenue projections. Regulatory risks also remain a concern.4. Caterpillar (CAT-US)Target Price (Feb 18, 2025): $195Target Price (Jan 24, 2025): $390Decline: -50.0%Key Issue: Concerns over a global economic slowdown affecting the construction and mining equipment market. Delayed infrastructure investments and supply chain uncertainties have been major factors in the target price cut.5. FMC (FMC-US)Target Price (Feb 18, 2025): $94Target Price (Jan 24, 2025): $123Decline: -23.6%Key Issue: Uncertain demand for agricultural chemicals, rising costs, and intensifying competition have pressured earnings estimates.6. Kraft Heinz (KHC-US)Target Price (Feb 18, 2025): $67Target Price (Jan 24, 2025): $89Decline: -25.1%Key Issue: Rising raw material costs and shifting consumer spending habits continue to impact the consumer goods sector. While brand strength remains a priority, short-term profitability concerns persist.7. Microchip Technology (MCHP-US)Target Price (Feb 18, 2025): $88Target Price (Jan 24, 2025): $102Decline: -13.7%Key Issue: While semiconductor industry conditions are expected to improve in the second half of the year, short-term inventory adjustments and reduced capital expenditures have led to a target price downgrade.8. Mondelez International (MDLZ-US)Target Price (Feb 18, 2025): $62Target Price (Jan 24, 2025): $71Decline: -12.7%Key Issue: Slower growth in global consumer markets and rising input costs are putting pressure on margins. With high exposure to emerging markets, currency fluctuations also pose risks.9. ON Semiconductor (ON-US)Target Price (Feb 18, 2025): $77Target Price (Jan 24, 2025): $89Decline: -13.5%Key Issue: Despite strong demand for automotive semiconductors, concerns over a potential global economic slowdown and weak IT & consumer electronics demand have led to a downward revision in forecasts.10. Skyworks Solutions (SWKS-US)Target Price (Feb 18, 2025): $100Target Price (Jan 24, 2025): $120Decline: -16.7%Key Issue: Weakening 5G-related component demand and increasing competition in the smartphone market pose significant risks. There are also concerns about a lack of differentiation compared to competitors.11. West Pharmaceutical (WST-US)Target Price (Feb 18, 2025): $301Target Price (Jan 24, 2025): $377Decline: -20.2%Key Issue: Concerns about raw material supply issues and competitive pressures in the pharmaceutical and medical device industries. Additionally, with the decline of COVID-19-driven demand, revenue growth is expected to slow.While the reasons and extent of target price downgrades vary by company, overall, these revisions reflect common macroeconomic risks, such as economic recession fears, supply chain uncertainties, rising costs, intensifying competition.Additionally, some companies are affected by structural industry changes, such as fluctuations in EV battery demand and semiconductor industry trends.From a sell-side perspective, stocks experiencing significant target price cuts could face short-term downside pressure. Investors should consider risk management strategies, including portfolio rebalancing, short positions, market-driven adjustments – Stay alert to upcoming earnings reports, interest rate changes, and key economic indicators, as these can significantly impact volatility.By aligning investment decisions with broader market trends, investors can navigate these shifts with greater flexibility and strategic foresight.

article

Strong Sell

AMD

Advanced Micro Devices

+10

Economy & Strategy

셀스마트 대니

SOX Surges 18.74% — Largest One-Day Gain in History (Apr 10, 2025)

Sell

NVDA

NVIDIA

+3

셀스마트 대니

SOX Surges 18.74% — Largest One-Day Gain in History (Apr 10, 2025)

The Philadelphia Semiconductor Index (SOX) soared 18.74% on April 9 (local time), marking its largest single-day percentage gain since the index was established in May 1994.The rally was triggered by President Donald Trump’s announcement to suspend reciprocal tariffs for 90 days on all countries except China. The decision was widely interpreted as a step toward easing global trade tensions and immediately lifted sentiment in a market that had been weighed down by tariff-related uncertainty.The SOX, which is heavily weighted toward AI and high-performance semiconductor companies, emerged as a direct beneficiary of the move.While the sharp rebound delivered a powerful boost to the tech sector, it also raised concerns about potential overheating following a prolonged market correction.[Compliance Note]All posts by Sellsmart are for informational purposes only. Final investment decisions should be made with careful judgment and at the investor’s own risk.The content of this post may be inaccurate, and any profits or losses resulting from trades are solely the responsibility of the investor.Core16 may hold positions in the stocks mentioned in this post and may buy or sell them at any time.

article

Sell

NVDA

NVIDIA

+3